Sucroferric oxyhydroxide Generics

Form: Chewable Tablet

Strength: 500mg

Reference Brands: Velphoro® (EU & US)

Category: Nephrology

Sucroferric oxyhydroxide is a next-generation, iron-based phosphate binder widely used in the nephrology sector for managing hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis. With a strong safety profile and proven efficacy, it offers a convenient, low-pill burden option compared to traditional binders. The product is in high demand across EU and US B2B pharmaceutical markets, driven by rising CKD prevalence and increasing dialysis patient numbers. Ideal for licensing, distribution, and contract manufacturing partnerships, sucroferric oxyhydroxide presents a strategic opportunity for companies targeting renal care therapeutics in regulated markets. Secure your position in this growing nephrology segment today.